GLOBAL ANTIBIOTIC RESISTANCE MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)

Global Antibiotic Resistance Market, By Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, Cephalosporins, Others), By Disease (cUTI (Complicated Urinary Tract Infections), CDI (Clostridioides difficile Infection), ABSSSI (Acute bacterial skin and skin structure infections), HABP (Hospital-acquired bacterial pneumonia), CABP (Community-acquired pneumonia), cIAI (Complicated intra-abdominal infection), Others (BSI (Bloodstream infection), etc.)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa).

Published In : Feb 2024
Code : CMI6668
Pages :180
Formats :
Excel and PDF
Industry : Pharmaceutical

Global Antibiotic Resistance Market Size and Trends

The global antibiotic resistance market was valued US$ 8.83 Bn in 2023 and is expected to reach US$ 13.37 Bn by 2031, growing at a compound annual growth rate (CAGR) of 5.3% from 2024 to 2031.

Figure 1. Global Antibiotic Resistance Market Share (%), By Region, 2023

Figure 2. Global Antibiotic Resistance Market Share (%), By Drug Class, 2023

Global Antibiotic Resistance Market – Trends

Adoption of newer technologies like AI and analytics by staffing agencies: Antibiotic resistance is significantly influencing the global antibiotic resistance market. Due to the rising threat of widespread antibiotic resistance, there is growing emphasis on developing rapid and accurate diagnostics to detect antibiotic-resistant bacterial infections. Novel antibiotic resistance diagnostics allow physicians to prescribe tailored antibiotic treatment based on the specific bacteria and their drug sensitivities, thereby ensuring appropriate usage of antibiotics.
Drug resistance bacteria surveillance systems: Drug resistance bacteria are becoming a major threat across the world as many common bacterial infections are now becoming harder to treat due to the overuse and misuse of antibiotics. According to data from the World Health Organization (WHO), antibiotic resistance is rising to dangerously high levels in all parts of the world. As per their latest global report on antimicrobial resistance published in 2022, antibiotic-resistant bacteria have been identified in every region assessed. If no action is taken, drug-resistant diseases could cause 10 million deaths each year by 2050.